G. Plewe

2.1k total citations
19 papers, 1.6k citations indexed

About

G. Plewe is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, G. Plewe has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in G. Plewe's work include Growth Hormone and Insulin-like Growth Factors (8 papers), Pituitary Gland Disorders and Treatments (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). G. Plewe is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (8 papers), Pituitary Gland Disorders and Treatments (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). G. Plewe collaborates with scholars based in Germany, United States and Japan. G. Plewe's co-authors include Robert S. Sherwin, Sonia Caprio, H. U. Janka, William V. Tamborlane, Stephanie A. Amiel, Donald C. Simonson, Matthias Axel Schweitzer, Matthew C. Riddle, Hannele Yki‐Järvinen and Eugene J. Barrett and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

G. Plewe

19 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Plewe Germany 14 1.1k 350 329 288 223 19 1.6k
Pierre-François Bougnères France 20 733 0.7× 559 1.6× 533 1.6× 601 2.1× 432 1.9× 53 1.8k
P E Belchetz United Kingdom 23 1.7k 1.5× 279 0.8× 362 1.1× 327 1.1× 169 0.8× 55 2.4k
M O Savage United Kingdom 23 1.2k 1.0× 501 1.4× 292 0.9× 557 1.9× 90 0.4× 67 1.7k
Sebastiano Grasso Italy 22 409 0.4× 308 0.9× 414 1.3× 351 1.2× 146 0.7× 75 1.4k
Abdollah Sadeghi‐Nejad United States 20 356 0.3× 295 0.8× 151 0.5× 220 0.8× 169 0.8× 46 925
Meyer Knobel Brazil 23 1.2k 1.1× 310 0.9× 332 1.0× 157 0.5× 110 0.5× 70 1.5k
D A Pyke United Kingdom 16 412 0.4× 164 0.5× 262 0.8× 395 1.4× 122 0.5× 39 1.0k
N Yordam Türkiye 20 523 0.5× 290 0.8× 149 0.5× 232 0.8× 94 0.4× 51 1.1k
Christine Trivin France 27 661 0.6× 677 1.9× 233 0.7× 412 1.4× 54 0.2× 56 1.8k
J. D. N. Nabarro United States 22 667 0.6× 172 0.5× 297 0.9× 106 0.4× 215 1.0× 46 1.3k

Countries citing papers authored by G. Plewe

Since Specialization
Citations

This map shows the geographic impact of G. Plewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Plewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Plewe more than expected).

Fields of papers citing papers by G. Plewe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Plewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Plewe. The network helps show where G. Plewe may publish in the future.

Co-authorship network of co-authors of G. Plewe

This figure shows the co-authorship network connecting the top 25 collaborators of G. Plewe. A scholar is included among the top collaborators of G. Plewe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Plewe. G. Plewe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Janka, H. U., G. Plewe, & Klaus Busch. (2007). Combination of Oral Antidiabetic Agents with Basal Insulin Versus Premixed Insulin Alone in Randomized Elderly Patients with Type 2 Diabetes Mellitus. Journal of the American Geriatrics Society. 55(2). 182–188. 59 indexed citations
2.
3.
Plewe, G., et al.. (2004). Comparing Daily Glycaemic Control with Insulin Glargine added to Oral Agents versus Twice-daily Premixed Insulin Alone in Type 2 Diabetes. 30 indexed citations
4.
Caprio, Sonia, Susan D. Boulware, Martin Press, et al.. (1992). Effect of growth hormone treatment on hyperinsulinemia associated with turner syndrome. The Journal of Pediatrics. 120(2). 238–243. 35 indexed citations
5.
Amiel, Stephanie A., Sonia Caprio, Robert S. Sherwin, et al.. (1991). Insulin Resistance of Puberty: a Defect Restricted to Peripheral Glucose Metabolism*. The Journal of Clinical Endocrinology & Metabolism. 72(2). 277–282. 227 indexed citations
6.
Jacob, Ralph, Eugene J. Barrett, G. Plewe, K. D. Fagin, & R. S. Sherwin. (1989). Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.. Journal of Clinical Investigation. 83(5). 1717–1723. 239 indexed citations
7.
Caprio, Sonia, G. Plewe, Michael P. Diamond, et al.. (1989). Increased insulin secretion in puberty: A compensatory response to reductions in insulin sensitivity. The Journal of Pediatrics. 114(6). 963–967. 240 indexed citations
8.
Plewe, G., U. Krause, U. Cordes, & J. Beyer. (1988). Evaluation of the clonidine-suppression test in the diagnosis of pheochromocytoma. Journal of Molecular Medicine. 66(17). 764–767. 7 indexed citations
9.
Simonson, Donald C., Stephanie A. Amiel, G. Plewe, et al.. (1988). Insulin Resistance and Hyperinsulinemia in Patients with Thalassemia Major Treated by Hypertransfusion. New England Journal of Medicine. 318(13). 809–814. 163 indexed citations
10.
Plewe, G., Udo Schneider, Ulrich Krause, & J. Beyer. (1987). Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans. Journal of Endocrinological Investigation. 10(2). 137–141. 15 indexed citations
11.
12.
Plewe, G., et al.. (1986). Somatostatin Analogue SMS 201-995 in Type I Diabetes Mellitus: Initial Experience after Repeated Administration. Scandinavian Journal of Gastroenterology. 21(sup119). 166–169. 16 indexed citations
13.
Schrezenmeir, J., G. Plewe, Wilhelm Stürmer, et al.. (1986). Treatment of APUDomas with the Long-Acting Somatostatin Analogue SMS 201-995: Investigations of Therapeutic Use and Digestive Side Effects. Scandinavian Journal of Gastroenterology. 21(sup119). 223–227. 16 indexed citations
14.
Plewe, G., J. Schrezenmeir, Ulrich Krause, et al.. (1986). Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995 over 6 months. Journal of Molecular Medicine. 64(8). 389–392. 19 indexed citations
15.
Plewe, G., J. Beyer, U. Krause, et al.. (1985). Comparison of131I-metaiodobenzylguanidine scintigraphy with urinary and plasma catecholamine determinations in the diagnosis of pheochromocytoma. Journal of Molecular Medicine. 63(14). 627–630. 11 indexed citations
16.
Plewe, G., et al.. (1985). Variability of GH Response to GRF Shows No Relationship with Peripheral Somatostatin and Somatomedin C Levels. Hormone and Metabolic Research. 17(9). 481–481. 1 indexed citations
17.
Plewe, G., Ulrich Krause, J. Beyer, Michel Neufeld, & E. del Pozo. (1984). LONG-ACTING AND SELECTIVE SUPPRESSION OF GROWTH HORMONE SECRETION BY SOMATOSTATIN ANALOGUE SMS 201-995 IN ACROMEGALY. The Lancet. 324(8406). 782–784. 141 indexed citations
18.
Plewe, G., et al.. (1984). Suppression of GH-secretion to normal values by a long-acting analogue of somatostatin in acromegaly. European Journal of Endocrinology. 104(4_Supplb). S30–S30. 3 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre-François Bougnères Breakdown of academic impact, for papers by P E Belchetz Breakdown of academic impact, for papers by M O Savage Breakdown of academic impact, for papers by Sebastiano Grasso Breakdown of academic impact, for papers by Abdollah Sadeghi‐Nejad Breakdown of academic impact, for papers by Meyer Knobel Breakdown of academic impact, for papers by D A Pyke Breakdown of academic impact, for papers by N Yordam Breakdown of academic impact, for papers by Christine Trivin Breakdown of academic impact, for papers by J. D. N. Nabarro
Rankless by CCL
2026